Internet of Things - IOT Market Research Reports

Although IoT is still coming into focus for many, it already connects more than nine billion devices worldwide; over the next five years, that number is expected to grow to between 20 billion and 50 billion devices. In 2025, IoT is expected to create between $4 trillion to $11 trillion in economic benefits globally. IoT is a logistical and economic...

This Frost & Sullivan market insight presents an analysis of the North American machine-to-machine (M2M) and Internet of Things (IoT) asset lifecycle management market. It highlights the key steps in M2M and IoT solution design, development, deployment, and management, and it discusses the key success factors for M2M and IoT solution providers. It ...

Recent Frost & Sullivan research identifies the Internet of Things (IoT) as one of the most important Mega Trends for todays organizations to consider. IoT-enabled devices are programmed to alert the users to anomalies which could indicate problems that require immediate attention. Users reach into data repositories to uncover causes and obtain in...

The United States prebiotics market is currently in a growth stage and is expected to experience considerable development throughout the forecast period. Growth of the market will be driven by the increasing demand for functional foods in the United States as consumers become more aware of the benefits of prebiotics beyond digestive health. Further...

This Frost & Sullivan market insight identifies the key competitive attributes for machine-to-machine (M2M) and Internet of Things (IoT) virtual network operators (VNOs) in North America. It also highlights the strengths, opportunities, and challenges for the leading M2M VNOs.

This study looks at emerging trends in the radiosurgery market and the residual impact of the financial crisis from both a market and an end-user hospital perspective. Stereotactic Radiosurgery (SRS) is an advanced form of radiotherapy capable of synchronizing tumor detection, surgical guidance, and radiation delivery components in a manner that ca...

This issue of Vital Signs, released on August 23, 2010, provides a strategic analysis of trends in biomarkers for improved and accelerated sepsis treatment. Additionally, a company spotlight is provided for BRAHMS, a global biotechnology company committed to improving healthcare through the discovery and development of novel and innovative bio...